[go: up one dir, main page]

IE891407L - Side chain unsaturated 1-ó-hydroxyvitamin d homologs - Google Patents

Side chain unsaturated 1-ó-hydroxyvitamin d homologs

Info

Publication number
IE891407L
IE891407L IE891407A IE140789A IE891407L IE 891407 L IE891407 L IE 891407L IE 891407 A IE891407 A IE 891407A IE 140789 A IE140789 A IE 140789A IE 891407 L IE891407 L IE 891407L
Authority
IE
Ireland
Prior art keywords
side chain
diseases
activity
hydroxyvitamin
homologs
Prior art date
Application number
IE891407A
Other versions
IE67953B1 (en
Inventor
Hector Deluca
Heinrich K Schnoes
Kato L Perlman
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of IE891407L publication Critical patent/IE891407L/en
Publication of IE67953B1 publication Critical patent/IE67953B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

This invention provides novel vitamin D-related compounds characterized by extended unsaturated side chain structures. Such compounds exhibit increased activity in arresting the proliferation and promoting the differentiation of malignant cells with only minimal calcemic activity and thus represents new therapeutic agents applicable and uniquely useful in differentiation therapy of malignant diseases. The activity characteristics of these compounds provide the basis of a method for the treatment of neoplastic diseases, specifically leukemoid diseases. [GB2217716A]
IE140789A 1988-04-29 1989-04-28 Side Chain Unsaturated 1alpha-Hydroxyvitamin D Homologs IE67953B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US18767588A 1988-04-29 1988-04-29

Publications (2)

Publication Number Publication Date
IE891407L true IE891407L (en) 1989-10-29
IE67953B1 IE67953B1 (en) 1996-05-15

Family

ID=22689977

Family Applications (1)

Application Number Title Priority Date Filing Date
IE140789A IE67953B1 (en) 1988-04-29 1989-04-28 Side Chain Unsaturated 1alpha-Hydroxyvitamin D Homologs

Country Status (13)

Country Link
EP (1) EP0374219A1 (en)
JP (1) JPH0699454B2 (en)
KR (1) KR940003360B1 (en)
AU (1) AU629831B2 (en)
FR (1) FR2630739A1 (en)
GB (1) GB2217716A (en)
HU (1) HU206316B (en)
IE (1) IE67953B1 (en)
IL (1) IL90065A (en)
IN (1) IN169818B (en)
NL (1) NL8920392A (en)
RU (1) RU2057117C1 (en)
WO (1) WO1989010352A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5225579A (en) * 1988-03-16 1993-07-06 Hoxan Corporation Method of manufacturing vitamin D2, Vitamin D3, activated type vitamin D2, activated type vitamin D3, and their derivatives
US4927815A (en) * 1988-04-29 1990-05-22 Wisconsin Alumni Research Foundation Compounds effective in inducing cell differentiation and process for preparing same
JPH0325053A (en) * 1989-06-23 1991-02-01 Takata Kk Pretensioner device
GB8914963D0 (en) * 1989-06-29 1989-08-23 Leo Pharm Prod Ltd Chemical compounds
US5260290A (en) * 1990-02-14 1993-11-09 Wisconsin Alumni Research Foundation Homologated vitamin D2 compounds and the corresponding 1α-hydroxylated derivatives
US5030772A (en) * 1990-02-14 1991-07-09 Deluca Hector F Process for preparing vitamin D2 compounds and the corresponding 1 α-hydroxylated derivatives
DE4221961A1 (en) * 1992-06-30 1994-01-05 Schering Ag 22-en-25-oxa derivatives in the vitamin D series, processes for their preparation, pharmaceutical preparations containing these derivatives and their use as medicines
US5565589A (en) * 1993-11-03 1996-10-15 Wisconsin Alumni Research Foundation 17-formyl-5,6-trans-vitamin D compounds
DE69508895T2 (en) * 1994-12-14 1999-10-21 Duphar International Research B.V., Weesp Vitamin D derivatives and methods of making these compounds
US8377913B2 (en) * 2007-11-20 2013-02-19 Abbvie Inc. Vitamin D receptor activators and methods of making

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH672920A5 (en) * 1984-10-04 1990-01-15 Wisconsin Alumni Res Found
EP0211863B1 (en) * 1985-01-17 1992-12-30 Wisconsin Alumni Research Foundation Vitamin d derivatives and methods for preparing same
US5206229A (en) * 1988-04-21 1993-04-27 Leo Pharmaceutical Products Ltd Vitamin d analogues

Also Published As

Publication number Publication date
KR940003360B1 (en) 1994-04-21
EP0374219A1 (en) 1990-06-27
IN169818B (en) 1991-12-28
IE67953B1 (en) 1996-05-15
WO1989010352A1 (en) 1989-11-02
RU2057117C1 (en) 1996-03-27
FR2630739A1 (en) 1989-11-03
HU206316B (en) 1992-10-28
AU3553389A (en) 1989-11-24
HU894747D0 (en) 1990-06-28
IL90065A0 (en) 1989-12-15
JPH02504149A (en) 1990-11-29
GB8909573D0 (en) 1989-06-14
AU629831B2 (en) 1992-10-15
GB2217716A (en) 1989-11-01
KR900700448A (en) 1990-08-13
NL8920392A (en) 1990-04-02
JPH0699454B2 (en) 1994-12-07
HUT52476A (en) 1990-07-28
IL90065A (en) 1996-05-14

Similar Documents

Publication Publication Date Title
DE69006052D1 (en) 19-nor vitamin D derivatives.
GR3019450T3 (en) Azaheterocyclylmethyl-chromans as agents for the treatment of diseases of the central nervous system
EP0933995B8 (en) Method of treating endothelial injury
EP0379806A3 (en) Pyrimidines and their pharmaceutical acceptable salts, and their use as medicines
IE891406L (en) Compounds effective in inducing cell differentiation and¹process for preparing same
CA2276606A1 (en) Method of treating prostatic diseases using active vitamin d analogues
DE69434211D1 (en) PHENYLACETATE AND DERIVATIVES, ALONE OR IN COMBINATION WITH OTHER COMPOUNDS, FOR THE TREATMENT OF NEOPLASTIC AND OTHER DISEASES
AU4180593A (en) The use of complement inhibitors for the preparation of a pharmaceutical for the prophylaxis and therapy of inflammatory intestinal and skin disorders as well as purpura
AU3158993A (en) Transdermally administered system containing acetylsalicylic acid for thrombosis therapy and cancer prophylaxis
IE891407L (en) Side chain unsaturated 1-ó-hydroxyvitamin d homologs
ZA87884B (en) Therapeutic agent
DE69013797D1 (en) Brain-specific preparation with controlled delivery.
AU590783B2 (en) Therapeutic agent for treating hematopoietic diseases
GR3034338T3 (en) Therapeutic system for treating psoriasis
IE893618L (en) Lactamimides in the treatment of drug-resistant protozoal¹infections
EP0382411A3 (en) Delivery of cytotoxic agents
ES2068714T3 (en) PIRIMIDINE DERIVATIVES TO INCREASE ANTITUMORAL ACTIVITY.
HU911195D0 (en) Process for producing conjugates of difluor-glutaminic acid with pholic and antipholic acid being suitable for treating tumorous illnesses
DE59010513D1 (en) MEDICINES FOR TUMOR THERAPY WITH CONTROLLED AND REGULATED IMMUNE SYSTEM AND USE OF THE INDIVIDUAL SUBSTANCES FOR COMBINED THERAPY
CA2030346A1 (en) Treatment of cardiac dysfunction with 15-keto-prostaglandin compounds
AU4685389A (en) Pharmaceutical compositions and use thereof in the treatment of psoriasis
AU3406089A (en) Novel strobilurine derivatives, their preparation and their use
AU5513590A (en) Use of gestodene for the production of pharmaceutical agents
ZA897549B (en) Medicament for the treatment of diseases caused by retroviruses
AU2358788A (en) The use of GM-CSF in the treatment of a patient requiring high-dose chemo- or radiotherapy for cancer

Legal Events

Date Code Title Description
MM4A Patent lapsed